MR. SANJAY JHA
Co-Founder Colmed Pvt. Ltd

Sanjay Jha hails from a humble background. He was born and brought up in Darbhanga, Bihar and studied mostly in government school and college till class 12th before he joined IIT Kharagpur in 1992 for 5 yrs integrated masters in Exploration Geophysics. He opted for career in software programming after graduating in 1997. He started his career with Ramco Systems and then shifted his base to US where he worked with Liquid Audio (pioneers in music digital distribution with ipod like devices) and then GE Healthcare. It was his tenure at GE Healthcare that he had the opportunity to get exposure to system engineering, manufacturing and R&D. He feels proud to see some of his work done before 2006 on GE Lightspeed VCT CT scanner still available on current generation machines. 


Subsequently, he did his MBA at INSEAD (France) and came to J&J Medical India. And spent almost 5 years in J&J India in different sales and marketing senior management roles before getting into start-up life with Colmed (an E-commerce platform for medical devices) being his second start-up.

Game changers in Healthcare Sector

At Colmed (Collateral Medical) , he along with fellow promoter started with building first medical device focussed E-commerce platform . Unlike most of other players they took the path of working closely with Medical device manufacturers very early. Currently Colmed is partners with majority of large multinationals and significant number of domestic players and make their products available at the right price with focus on tier 2 and tier 3 cities of India. Colmed has supplied medical devices to over 1000 resellers and to over 75,000 unique customers across most of the pin codes in India.

The Driving Force

He is driven by the satisfaction he gets by contributing towards bringing down the cost of treatment in his own way. On bigger picture, healthcare costs for patients is climbing up day by day and he does his small bit in driving that cost down by increasing the efficiency of supply chain and aggregating medical device demand. While on day to day, to take an idea, break it in small executional pieces and then enabling his team to execute it makes his day better.

Interesting anecdote with this startup

He finds each and every day at the startup a new day filled with new learnings. As it happens with any startup, the founding team faced lots of challenges initially, but somehow they were able to figure out a way to rise above those challenges. Early on, they were advised to take marketplace route, but they always believed in inventory based model. Whereas marketplace route is preferred by many investors, but his market research precipitated the fact that there is hardly any marketplace being even EBITDA positive. Being the old school, they believed in business making money to survive and not-burning cash. Drawing parallels, they observed Cloudtail having positive EBITDA while Amazon burning more than 6000 crore in India in an year. They realized that for 1000cr annual turnover inventory requirement is hardly 100cr. Moreover, they relied on the fact that healthcare is an area where quality needs to be of paramount concern and with marketplace quality concerns are rampant. So, they stayed on the inventory led path, which meant slower but profitable growth for the startup.  

Setback moment

Mr Sanjay had another startup before Colmed, specializing in analytics space, where he worked extensively on energy forecasting using machine learning. After creating a wonderful product for year and half and successful pilot he had to shut the shop due to his lack of understanding of systems in govt sector leading to extreme delay procedures, permissions and protocols leading to delayed results. The experience taught him a lot about what not to do.

Eureka moment

While their online business soared newer highs, the team Colmed struggled in direct supplies to small hospital segment in tier2/tier3 due to their low per order size, payment challenges and in many cases need of urgent delivery. Thus while significant volume of business was gained but it was an EBITDA negative business. This forced them to strategise innovatively to sort out the challenge with limited resources. They started focusing on resellers, who were only one level above the hospitals in this prevailing multi-tier distribution systems in tier2/tier3 cities. This step worked wonders for them and currently they are able to drive more than 80% of their sale from tier2/tier3.

Funding so far/awards/associations and affiliations

So far Colmed has received over 5m USD funding through equity and debt.
He, along with other founders of Colmed were featured on cover page of silicon india, as one of the best healthcare startups.
 
3 messages for aspiring and budding entrepreneurs 
 
“Execution is the key to success, so don’t get stuck with good/bad idea, if you have assumptions try it and find it out if it works in limited scale.”
 
“Don’t be afraid of failure. My failure from my first startup taught me a lot.”
 
“Don’t stay away from people of who challenge you. Would be great if you have a mentor who can tell you that you are wrong. It makes you think harder and might save you significant valuable time and money.”


Vision for next 5 years

At Colmed, he wants to first increase the reach to at least 20,000 resellers in Tier2/Tier3 market. Then he wants to build further on his tech platform to help them streamline their demand planning, inventory management and provide them easy access to financing by partnering with Fintechs. On the product side, he wants to build private label business which already has started doing very well for them, and create a sustainable above 12% EBITDA business.
 
Message to readers through Voice of Healthcare Platform
 
“When life is comfortable then it might get boring, so get out of your comfort zone and make your life more exciting.
We all have many weaknesses, so why not focus on strengths and get the best out of ourselves...!!!!”

 

Subscribe Our Newsletter

MR. SANJAY JHA
By: - 2020-08-08 22:42:23

NEWS

By: Staff Writer-21 Aug, 2020

By: Bloomberg-21 Sept, 2020

By: PTI-21 Sept, 2020

By: AFP-21 Sept, 2020

By: PTI-21 Sept, 2020

#

By: Bloomberg-18 Sept, 2020

#

By: Leroy Leo-18 Sept, 2020

#

By: Anulekha Ray-19 Sept, 2020

#

By: REUTERS-20 Sept, 2020

By: Reuters-18 Sept, 2020

By: Serena Gordon-18 Sept, 2020

By: Dennis Thompson-18 Sept, 2020

By: Alan Mozes-18 Sept, 2020

By: AFP-18 Sept, 2020

By: Bloomberg-18 Sept, 2020

By: PTI-17 Sept, 2020

By: PTI-17 Sept, 2020

By: Serena McNiff-17 Sept, 2020

By: PTI-17 Sept 2020

By: Heidi Ledford-16 Sept, 2020

By: Alison Abbott-16 Sept, 2020

By: Michael Marshall-16 Sept, 2020

By: Carolyn Crist-16 Sept, 2020

By: Clare Watson-16 Sept, 2020

By: Michelle Cortez , Bloomberg-15 Sept, 2020

By: Anonymous-15 Sept, 2020

By: David Cyranoski & Smriti Mallapaty-15 Sept, 2020

By: Reuters-15 Sept, 2020

By: Reuters-15 Sept, 2020

By: Noah Higgins-Dunn & Christina Farr-15 Sept, 2020

By: Kevin Stankiewicz-15 Sept, 2020

By: Sam Shaed-15 Sept, 2020

By: PTI-14 Sept, 2020

By: Anonymous-13 Sept, 2020

By: Anonymous-13 Sept, 2020

By: Anonymous-13 Sept, 2020

By: Anonymous-13 Sept, 2020

By: Anonymous-12 Sept 2020

By: Anonymous-12 Sept 2020

By: Ralph Ellis-12 Sept 2020

By: Anonymous-12 Sept 2020

By: Newsroom-12 Sept 2020

By: Newsroom-12 Sept 2020

#

By: Mint News-10 Sep 2020

#

By: Kathleen Doheny-08 Sept 2020

#

By: Linda A. Johnson-08 Sept 2020

#

By: Nature-09 Sept 2020

#

By: Lauran Neergaard-09,Sept, 2020

#

By: Surajit Dasgupta-08, Sept, 2020

#

By: HealthDay Reporter-04 Sept2 020

By: PTI-08 Sept, 2020

By: Jon Emont , The Wall Street Journal-08 Sept, 2020

By: John McCormick-08 Sept, 2020

By: The Associated Press-08 Sept, 2020

By: PTI-08 Sept, 2020

By: AP News-08 Sept, 2020

By: Joslin Diabetes Center-05 Sept, 2020

By: Suzi Ring , Bloomberg-05 Sept, 2020

By: Peter Loftus-05 Sept, 2020

By: Robert Preidt-05 Sept, 2020

By: Serena Gordon-05 Sept, 2020

By: Kerry Dooley Young-05 Sept, 2020

By: Anonymous-05 Sept, 2020

By: Anonymous-04 Sept, 2020

By: Heidi Ledford-04 Sept, 2020

By: WEBMD NEWS BRIEF-04 Sept, 2020

#

By: Brenda Goodman, MA-04 Sept, 2020

#

By: Newsroom-04 Sept, 2020

#

By: PTI-3 Sept, 2020

By: Kate Kelland , Reuters-3 Sept, 2020

#

By: Gayathri Vaidyanathan-03 Sept, 2020

#

By: Carolyn Crist-2 Sept, 2020

#

By: Neetu Chandra Sharma-2 Sept, 2020

#

By: Newsroom-2 Sept, 2020

#

By: Anonymous-2 Sept, 2020

#

By: Newsroom-2 Sept, 2020

#

By: BRUCE GOLDMAN-2 Sept, 2020

#

By: Newsroom-2 Sept, 2020

#

By: Newsroom-2 Sept, 2020

#

By: Reuters-1 Sep, 2020

#

By: Reuters-1 Sep, 2020

#

By: Reuters-1 Sep, 2020

#

By: Reuters-1 Sep, 2020

#

By: Reuters-1 Sep, 2020

#

By: Jeff Tollefson-1 Sep, 2020

#

By: Reuters-1 Sep, 2020

#

By: Heidi Ledford-1 Sep, 2020

#

By: Reuters-30 Aug, 2020

#

By: Reuters-30 Aug, 2020

#

By: Reuters-18 Aug, 2020

#

By: Ricardo Alonso-Zaldivar-30 Aug, 2020

#

By: Reuters-30 Aug, 2020

#

By: Reuters-30 Aug, 2020

#

By: Reuters-29 Aug, 2020

#

By: Reuters-29 Aug, 2020

#

By: Smriti Mallapaty-29 Aug, 2020

#

By: Newsroom-29 Aug, 2020

#

By: Reuters-29 Aug, 2020

#

By: Reuters-29 Aug, 2020

#

By: Reuters-29 Aug, 2020

#

By: Sachin Ravikumar, Derek Francis, Nivedita Bhattacharjee-26 Aug, 2020

#

By: Reuters-26 Aug, 2020

#

By: Giorgia Guglielmi-21 Aug, 2020

#

By: Reuters-25 Aug, 2020

#

By: Anulekha Ray-24 Aug, 2020

#

By: All India | ANI-26 Aug, 2020

#

By: Andrew Meldrum, Mogomotsi Magome and Lauran Neergaard-26 Aug, 2020

#

By: LONDON (Reuters)-26 Aug, 2020

#

By: Dr. Eric Nudleman-25 Aug, 2020

#

By: PTI-25 Aug, 2020

#

By: LiveMint-25 Aug, 2020

#

By: Junko Fujita-25 Aug, 2020

#

By: Reuters-25 Aug, 2020

#

By: Nandita Bose, Aram Roston-25 Aug, 2020

#

By: FP Staff-25 Aug, 2020

Study Adds to Evidence That Odor-Sensing

By: Newsroom-24 Aug, 2020

Covid-19 vaccine update: Pfizer, BioNTec

By: FE Online-24 Aug, 2020

Covid-19 vaccine update: Cuba, N Korea,

By: FE Online-24 Aug, 2020

COVID-19 recovery rate reaches 74.69 per

By: PTI-24 Aug, 2020

COVID-19 caseload in India crosses 30-la

By: PTI-24 Aug, 2020

Factbox: Latest on the worldwide spread

By: Reuters-24 Aug, 2020

India crosses crucial milestone of testi

By: PTI-23 Aug, 2020

COVID-19 diagnostic test: Saliva-based t

By: FE Online-23 Aug, 2020

COVID-19: India adds nearly 70,000 cases

By: FE Online-23 Aug, 2020

Novartis immuno-oncology drug candidate

By: Reuters-23 Aug, 2020

#

By: PTI-23 Aug, 2020

#

By: Reuters-23 Aug, 2020

Coronavirus Updates: Maharashtra reports

By: FP Staff-21 Aug, 2020

Russia's 'Sputnik V' COVID-19 vaccine to

By: Reuters-21 Aug, 2020

Asia Today: India has record high of 69,

By: AP-21 Aug, 2020

Endless first wave: how Indonesia failed

By: Reuters-21 Aug, 2020

Diagnostics firms eye consolidation

By: livemint-21 Aug, 2020

Accuracy Problems with Widely Used Coron

By: Associated Press-21 Aug, 2020

Coronavirus is Not Ready to Budge, So Wh

By: N C Satpathy-20 Aug, 2020

What Is Digital Health ID? Here’s What Y

By: Jagmeet Singh-20 Aug, 2020

How Much Vitamin C Is Too Much Vitamin C

By: Rupali Dutta-20 Aug, 2020

One in four Indians could have been infe

By: Savio Shetty-20 Aug, 2020

Roche, Regeneron link up on COVID-19 ant

By: Reuters-19 Aug, 2020

Explainer: World Health Organization's s

By: Reuters-19 Aug, 2020

Australia hails vaccine deal as virus su

By: Reuters-19 Aug, 2020

COVID-19: Govt to review guidelines to s

By: FE Online-19 Aug, 2020

Coronavirus vaccine update: India begins

By: FE Online-19 Aug, 2020

Immune response after mild COVID-19 is p

By: Reuters-19 Aug, 2020

Recovered cases 2.93 times the number of

By: livemint-19 Aug, 2020

Study links COVID-19 to rise in childhoo

By: Reuters-19 Aug, 2020

WHO blasts 'vaccine nationalism' in last

By: Reuters-19 Aug, 2020

Novavax begins mid-stage study of COVID-

By: Reuters-18 Aug, 2020

COVID-19 vaccine: Do vaccines need to be

By: FE Online-18 Aug, 2020

Russia to roll out vaccine by end of Aug

By: Financial Express-18 Aug, 2020

Testing of CanSino's COVID-19 candidate

By: Reuters-18 Aug, 2020

COVID-19 warriors will be first to get v

By: PTI-18 Aug, 2020

Covid-19, Cold, Flu or Allergy: Know the

By: HT?Correspondent Hindustan Times-17 Aug, 2020

Eat Right, Smile Bright - Acidic Food an

By: FP Studio-17 Aug, 2020

Coronavirus Updates: Karnataka reports 7

By: FP Staff-17 Aug, 2020

Health ID pilot programme to start with

By: FE Online-17 Aug, 2020

Mexico needs 200 million COVID-19 vaccin

By: Reuters-17 Aug, 2020

Factbox: Latest on worldwide coronavirus

By: Reuters-17 Aug, 2020

The Latest: S. Korea reports largest vir

By: The Associated Press-16 Aug, 2020

PM Modi announces launch of National Dig

By: By EH News Bureau-16 Aug, 2020

Russian doctors wary of rapidly approved

By: Reuters-16 Aug, 2020

Need to wage war against NCDs, not just

By: By EH News Bureau-16 Aug, 2020

COVID-19 during pregnancy shows no affec

By: Dr. Liji Thomas-15 Aug, 2020

Has Delhi flattened COVID-19 curve?

By: CitizeMatters.in-15 Aug, 2020

Acupuncture may help with inflammation a

By: Myupchar-15 Aug, 2020

PM Modi to launch National Digital Healt

By: ET Bureau-15 Aug, 2020

WHO says food safe from coronavirus

By: AFP-15 Aug, 2020

Why flu vaccines do not protect people f

By: ScienceMag.org-15 Aug, 2020

Amid Covid-19 fear, Delhi hospital condu

By: ANI-14 Aug, 2020

A new way to monitor skin cancer: Scient

By: Myupchar-14 Aug, 2020

Covid-19: Human trials of Oxford vaccine

By: FE Online-14 Aug, 2020

Coronavirus India Live: Recovery rate in

By: FE Online-14 Aug, 2020

Zydus Cadila launches Indias cheapest re

By: FE Bureau-14 Aug, 2020

NHA governing board gives nod to integra

By: PTI-14 Aug, 2020

ePharmacies to tap approx 70 million Ind

By: EH News Bureau-14 Aug, 2020

Novavax Reports Encouraging Vaccine Resu

By: Carolyn Crist-05 Aug, 2020

"Patients From Outside": Delhi Health Mi

By: DelhiPress Trust of India-09 Aug, 2020

Billion Covid Vaccine Doses Could Be Ava

By: WorldReuters-06 Aug, 2020

New drug RLF-100 shows dramatic recovery

By: PTI-06 Aug, 2020

Biz of this immunity food not in the bes

By: Mayilvaganan-06 Aug, 2020

Read More

Partners & Associates